You have 9 free searches left this month | for more free features.

prednisone

Showing 1 - 25 of 945

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hepatocellular Carcinoma Trial (Prednisone)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Prednisone
  • (no location specified)
Jun 2, 2023

In-stent Restenosis Trial in Beijing (Colchicine, Prednisone, Aspirin)

Not yet recruiting
  • In-stent Restenosis
  • Beijing, Beijing, China
    Fuwai Hospital
Oct 15, 2023

Acute Heart Failure Trial (Prednisone)

Not yet recruiting
  • Acute Heart Failure
  • Prednisone
  • (no location specified)
Jun 14, 2023

Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)

Not yet recruiting
  • Large B-Cell Lymphoma
  • Xi'an, China
    First Affiliated Hospital of Medical College of Xi'an Jiaotong U
Sep 14, 2023

Langerhans Cell Histiocytosis of Bone Trial in Shanghai (Prednisone)

Recruiting
  • Langerhans Cell Histiocytosis of Bone
  • Prednisone
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Oct 15, 2023

Nephrotic Syndrome in Children Trial (Huaiqihuang granule, Prednisone, Levamisole )

Not yet recruiting
  • Nephrotic Syndrome in Children
  • Huaiqihuang granule
  • +4 more
  • (no location specified)
Mar 6, 2023

Facial Swelling, Tooth Position Anomalies, Tooth, Impacted Trial in Catanzaro (Prednisone, Placebo)

Completed
  • Facial Swelling
  • +4 more
  • Prednisone
  • Placebo
  • Catanzaro, CZ, Italy
    Magna Graecia University of Catanzaro
Apr 23, 2023

Healthy, Atopic Dermatitis Trial in Daytona Beach (LY3872386, Prednisone, Placebo)

Not yet recruiting
  • Healthy
  • Atopic Dermatitis
  • Daytona Beach, Florida
    Fortrea Clinical Research Unit
Nov 1, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

Not yet recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +12 more
  • Biopsy
  • +8 more
  • (no location specified)
Jun 8, 2023

Lymphoma, Non-Hodgkin Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Vysis LSI MYC Break Apart Rearrangement

Recruiting
  • Lymphoma
  • +4 more
  • Vysis LSI MYC Break Apart Rearrangement Probe Kit
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Abiraterone Acetate/Niraparib
  • +5 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 9, 2023

Multiple Myeloma Trial in Saint Louis (Isatuximab, Bendamustine, Prednisone)

Recruiting
  • Multiple Myeloma
  • Isatuximab
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 21, 2022

Vasectomy Reversal Trial in Orem (Prednisone)

Recruiting
  • Vasectomy Reversal
  • Prednisone
  • Orem, Utah
    Cure PD
Jul 19, 2022

Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Advanced Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)

Active, not recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Abiraterone Acetate
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Gout, Chronic Kidney Disease, Renal Transplantation Trial in Paris (Anakinra 100Mg/0.67Ml Inj Syringe, Prednisone, Placebo of

Recruiting
  • Gout
  • +2 more
  • Anakinra 100Mg/0.67Ml Inj Syringe
  • +3 more
  • Paris, Ile-De-France, France
    Rhumathology department
Aug 22, 2022

Prostate Cancer Metastatic, Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone)

Recruiting
  • Prostate Cancer Metastatic
  • Prostate Cancer
  • Abiraterone Acetate
  • Prednisone
  • Houston, Texas
  • +2 more
Oct 7, 2022

B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent B Acute

Recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 16, 2022

Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Prostate Carcinoma Metastatic in the Bone Trial in Houston (Abiraterone

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +5 more
  • Abiraterone Acetate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 26, 2022

Immune Thrombocytopenia Trial in Beijing (Prednisone, Recombinant Human TPO)

Recruiting
  • Immune Thrombocytopenia
  • Prednisone
  • Recombinant Human TPO
  • Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Apr 17, 2022

Prostate Cancer Trial in United States (Docetaxel-PNP, Ribociclib, Prednisone)

Completed
  • Prostate Cancer
  • San Francisco, California
  • +5 more
Aug 9, 2022

Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the National Cancer Institute (NCI) (Venetoclax, Ibrutinib, Prednisone)

Recruiting
  • Lymphoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 20, 2022

Chronic GVHD Trial in Shanghai (SHR0302, Prednisone)

Recruiting
  • Chronic GVHD
  • Shanghai, Shanghai, China
  • +1 more
Aug 4, 2022

Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the NCI (obinutuzumab, prednisone, Revlimid)

Recruiting
  • Lymphoma
  • +3 more
  • obinutuzumab
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Inflammatory Arthritis, Immune-related Adverse Event Trial (Adalimumab, Prednisone)

Not yet recruiting
  • Inflammatory Arthritis
  • Immune-related Adverse Event
  • (no location specified)
Sep 13, 2023